1.
Vuoksimaa E, Saari TT, Aaltonen A, et al. TWINGEN - protocol for an observational clinical biobank recall and biomarker study to identify individuals with high risk of Alzheimer’s disease. medRxiv : the preprint server for health sciences. 2023. doi:10.1101/2023.11.03.23298018.
1.
Britton GB, Huang L-K, Villarreal AE, et al. Digital phenotyping: An equal opportunity approach to reducing disparities in Alzheimer’s disease and related dementia research. Alzheimer’s & dementia (Amsterdam, Netherlands). 2023;15(4):e12495. doi:10.1002/dad2.12495.
1.
Short MI, Fohner AE, Skjellegrind HK, et al. Proteome Network Analysis Identifies Potential Biomarkers for Brain Aging. Journal of Alzheimer’s disease : JAD. 2023;96(4):1767-1780. doi:10.3233/JAD-230145.
1.
Ajufo EC, Aragam KG. Improving Polygenic Risk Scores for Coronary Artery Disease: What Helps and by How Much?. JACC. Basic to translational science. 2023;8(12):1500-1502. doi:10.1016/j.jacbts.2023.10.005.
1.
Lin J, Mars N, Fu Y, et al. Integration of Biomarker Polygenic Risk Score Improves Prediction of Coronary Heart Disease. JACC. Basic to translational science. 2023;8(12):1489-1499. doi:10.1016/j.jacbts.2023.07.006.
1.
Parsons HA, Blewett T, Chu X, et al. Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030. Annals of oncology : official journal of the European Society for Medical Oncology. 2023. doi:10.1016/j.annonc.2023.08.004.
1.
Hubbard AK, Brown DW, Zhou W, et al. Serum biomarkers are altered in UK biobank participants with mosaic chromosomal alterations. Human molecular genetics. 2023. doi:10.1093/hmg/ddad133.
1.
Zhang F, Luna A, Tan T, Chen Y, Sander C, Guo T. COVIDpro: Database for Mining Protein Dysregulation in Patients with COVID-19. Journal of proteome research. 2023. doi:10.1021/acs.jproteome.3c00092.
1.
Sklavenitis-Pistofidis R, Aranha MP, Redd RA, et al. Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma. Cancer Cell. 2022;40(11):1358-1373.e8. doi:10.1016/j.ccell.2022.10.017.
1.
Manoli I, Sysol JR, Epping MW, et al. FGF21 underlies a hormetic response to metabolic stress in methylmalonic acidemia. JCI Insight. 2018;3(23). doi:10.1172/jci.insight.124351.